register

Marketing & Strategy

The future of the pharmaceutical and GP engagement model 

Health Industry Hub | March 18, 2020 |
[Total: 1    Average: 4/5]

As many GPs are no longer seeing pharma reps there is a growing demand for pharma companies to be forward-thinking and to look to innovative digital communication solutions, reveals a new industry white paper.   

The evolving commercial landscape provides the imperative for a new way of doing business. For pharma companies, this means recognising that GPs are time poor, and whilst choosing not to see drug reps, are raising their digital interactions with pharma. 

Half of GPs are choosing not to see drug reps. This leading to questions over what the future of pharma interactions look like, reveals a new industry white paper.

A series of surveys conducted by independent medical publisher Australian Doctor Group (ADG) shows more than half (54%) say they are too busy to see them, 53% believe they aren’t an objective source of information and 35% prefer to get their information from other places.

The decline in GP engagement is not for lack of trying on pharma’s part – with more than 40% of GP responders reporting that reps attempt to see them or speak to them in person every week.

The surveys’ findings are published for the first time in ADG’s The future of the pharmaceutical and GP engagement model white paper, which warns that the situation is set to worsen with rising GP workloads and a shift to sourcing clinical information online.

Latest Department of Health figures cited in the paper reveal Australian GPs are delivering 18% more services a year than they did a decade ago – leaving them increasingly time poor.

Meanwhile, qualitative research commissioned by ADG shows GPs are looking for real-time information and are routinely using Google searches during patient consults to make sure they have the most up-to-date information to hand.

Australian pharma companies have been slow to respond to this changing environment, the paper reveals

It highlights data from pharmaceutical consulting firm IQVIA that show, despite more GPs choosing not to see reps, investment in marketing materials for drug rep visits increased by 22% between 2015 and 2019.

However, the pharma companies and their marketing teams that are willing to embrace this new digital landscape and engage GPs in the ways they want are seeing strong positive results. 

Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


Leadership & Management

Leadership Management Qualities - Leaving an inspirational legacy by taking action and making a difference, says Medicines Australia CEO

Leaving an inspirational legacy by taking action and making a difference, Medicines Australia CEO

Health Industry Hub | September 20, 2021 |

Leadership & Management: Welcome to Health Industry Hub’s Women in Leadership Series – connecting, engaging and empowering women in the Pharma, […]

More


Human Resources

Human Resource Management - Winners revealed at 2021 Australian HR Awards; Johnson & Johnson the only healthcare company to secure a win

Winners revealed at 2021 Australian HR Awards; Johnson & Johnson the only healthcare company to secure a win

Health Industry Hub | September 20, 2021 |

Human Resources: The annual Australian HR Awards has been recognised as the leading independent awards event in the HR profession […]

More


News & Trends - Pharmaceuticals

Pharma News - MSD's Keytruda excels in early stage melanoma, reducing cancer recurrence post-surgery

MSD’s Keytruda excels in early stage melanoma, reducing cancer recurrence post-surgery

Health Industry Hub | September 20, 2021 |

Pharma News: Patients with stage IIB and IIC melanoma have a deep or ulcerated primary tumour. These patients occur in […]

More


News & Trends - Medical Technology

MedTech News - AAOS releases new trends from the hip and knee replacement registry

AAOS releases new trends from the hip and knee replacement registry

Health Industry Hub | September 20, 2021 |

MedTech News: The American Academy of Orthopaedic Surgeons (AAOS) Registry Program announced the availability of the American Joint Replacement Registry Program (AJRR) […]

More